
Yue Huang, PhD, EMBA.
Dr. Yue Huang graduated from Beijing Medical University School of Pharmacy. He obtained his Ph.D. in Pharmaceutics and Pharmacokinetics from University of Minnesota, USA.He also completed an executive MBA degree from Swiss Business School (SBS) in Zurich, Switzerland majoring in International and Strategic Management. Dr. Huang is a seasoned global R&D executive with 23+ years of pharmaceutical industry experience, with specialties in the clinical pharmacology and exploratory and late stage R&D. His career path includes Quintiles (Kansas City, Missouri), Roche (Palo Alto, California), Genentech (South San Francisco, California), Novartis (Basel, Switzerland), more recently, Merck Serono R&D Hub (Beijing) as the Head of Global Development & Translational Medicine China, Simcere Pharma Group (Nanjing) as R&D Executive Director, and currently as the Director of Shanghai Pharma – Hong Kong Science and Technology Park Co-Incubator.
Dr. Huang has worked directly in numerous pharmaceutical and biotechnology pipeline projects encompassing both small molecules, large biologics, and novel modalities including nucleic acid, cell and gene therapy, and spanning the entire project life-cycle from early discovery, preclinical, IND/NDA, to commercial stage.